Singapore-headquartered Mobile-health Network Solutions (MNDR), a leading AI-powered digital health platform, has announced the signing of a non-binding Strategic Cooperation Framework Memorandum of Understanding (MoU) with Hector Capital Holdings.
Under the framework, Hector Capital will invest up to $119m into Nasdaq-listed MNDR to support the acquisition of majority shareholdings in MILVIK Singapore (BIMA), a healthcare platform operating in Africa and Asia, and M&M Helix, a healthcare technology firm offering an AI-powered telemedicine and patient care platform.
This strategic partnership marks a significant milestone in MNDR's mission to expand its portfolio of AI-powered healthcare solutions across Africa and Asia.
MoU highlights
-
Capital Investment: Hector Capital to invest up to US$119 million in MNDR, with the funding structure to be finalized in the definitive agreements, which may include a combination of equity subscription, convertible instruments, and/or other financial instruments. Proceeds will be applied toward the acquisitions and for general corporate and operational purposes.
-
Acquisitions: MNDR to acquire majority stakes in BIMA and MM Helix, integrating them as subsidiaries.
-
Independent Valuation: Consideration for the acquisitions will be consistent with an independent valuation of BIMA and MM Helix to be commissioned and agreed to by the parties prior to execution of the definitive agreements, and remains subject to regulatory approvals under applicable Nasdaq listing rules and Singapore law.
Dr Siaw Tung Yeng, Co-CEO of MNDR, said, "This framework sets the stage for transformative growth. By integrating BIMA's healthcare ecosystem and MM Helix's AI-powered platform into MNDR, we are building a scalable, affordable healthcare network that empowers millions of families across emerging markets."
Completion remains subject to MNDR's full legal, financial, and operational due diligence on BIMA and MM Helix, independent valuation, and receipt of all necessary regulatory approvals, including those required under applicable Nasdaq listing rules and Singapore law.
M&M Helix: A Singapore-based digital healthcare technology firm offering an AI-powered telemedicine and patient care platform. MM Helix recently expanded its capabilities through the acquisition of Hyderabad-based health-tech firm Zibew, operator of DigitalRx.io, enabling a unified system for clinic and pharmacy workflows.
MILVIK BIMA: Founded in 2010, BIMA is a pioneer in democratising healthcare in emerging markets. Its platform provides affordable access to telemedicine, specialist care, health screening, personalized health programs, medicine delivery, laboratory testing, and insurance. Operating across Asia and Africa, BIMA serves millions of customers and is committed to making high-quality healthcare accessible to all.
Hector Capital Holdings is a Singapore-based investment firm with substantial indirect and beneficial shareholdings in regulated fund management entities VPAM and Brown Capital, operating across multiple jurisdictions. The firm specialises in strategic investments that combine capital deployment with operational value-add, supporting portfolio companies in scaling across Asia and beyond.
Through majority ownership interests in MILVIK Singapore (BIMA) and M&M Helix, Hector Capital has built a strong presence in the digital healthcare sector.
Mobile-health Network Solutions, with operations across Southeast Asia and expanding into the US, provides telemedicine, AI-driven health tools, and virtual clinic infrastructure to empower patients and doctors worldwide. Its mission is to make healthcare accessible, intelligent, and human through technology. For more information, please visit our website.